

CONMED will exit its gastroenterology product lines to focus on higher-growth surgical markets, aiming for long-term success.
You can purchase shares of Conmed (NYSE:CNMD) through any online brokerage.
Other companies in Conmed’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Conmed has a consensus price target of $51.88.
The stock price for Conmed (NYSE: CNMD) is $51.5 last updated November 6, 2026 at 4:00 PM EST.
There are no upcoming dividends for Conmed.
Conmed does not have any upcoming earnings scheduled.
There is no upcoming split for Conmed.
Conmed is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery,...